Quality Specifications for Medicinal Products

German Pharmacopoeia 2026 - DAB 2026

It is planned to amend the German Pharmacopoeia 2025 (DAB 2025, notification number 2024/0612/DE) in its current version and to implement the new version as the German Pharmacopoeia 2026. The announcement thereof will refer to the notification. The amendments requiring notification include the revised monographs and reagent descriptions to be included in the German Pharmacopoeia 2026, as well as the deletion of monographs and reagents. The draft text is attached as an annex.